Attached files

file filename
S-1/A - AMENDMENT NO.1 TO FORM S-1 - NovoCure Ltdd940664ds1a.htm
EX-10.16 - EX-10.16 - NovoCure Ltdd940664dex1016.htm
EX-23.2 - EX-23.2 - NovoCure Ltdd940664dex232.htm
EX-1.1 - EX-1.1 - NovoCure Ltdd940664dex11.htm
EX-3.5 - EX-3.5 - NovoCure Ltdd940664dex35.htm
EX-10.15 - EX-10.15 - NovoCure Ltdd940664dex1015.htm
EX-21.1 - EX-21.1 - NovoCure Ltdd940664dex211.htm
EX-10.14 - EX-10.14 - NovoCure Ltdd940664dex1014.htm
EX-3.4 - EX-3.4 - NovoCure Ltdd940664dex34.htm
EX-5.1 - EX-5.1 - NovoCure Ltdd940664dex51.htm
EX-10.5 - EX-10.5 - NovoCure Ltdd940664dex105.htm
EX-10.12 - EX-10.12 - NovoCure Ltdd940664dex1012.htm
EX-10.17 - EX-10.17 - NovoCure Ltdd940664dex1017.htm
EX-4.1 - EX-4.1 - NovoCure Ltdd940664dex41.htm
EX-10.18 - EX-10.18 - NovoCure Ltdd940664dex1018.htm

Exhibit 3.3

COMPANIES (JERSEY) LAW 1991

MEMORANDUM OF ASSOCIATION

Adopted by Special Resolution dated September 16, 2015

 

1 The name of the company is NOVOCURE LIMITED.

 

2 The company is a public company.

 

3 The company is a no par value company.

 

4 The share capital of the company is divided into an unlimited number of ordinary shares of no par value and an unlimited number of preferred shares of no par value (which preferred shares may be issued in such class or classes as the directors of the company may determine in accordance with the Articles of Association of the company).

 

5 The liability of any member arising from his holding of such a share is limited to the amount (if any) unpaid on it.